Robert Edward Sosnowski - Net Worth and Insider Trading

Robert Edward Sosnowski Net Worth

The estimated net worth of Robert Edward Sosnowski is at least $0 dollars as of 2024-11-13. Robert Edward Sosnowski is the VP, Sales & Marketing of Cyclacel Pharmaceuticals Inc and owns about 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $0. Details can be seen in Robert Edward Sosnowski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Edward Sosnowski has not made any transactions after 2010-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Edward Sosnowski

To

Robert Edward Sosnowski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Edward Sosnowski owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .

Click here to see the complete history of Robert Edward Sosnowski’s form 4 insider trades.

Insider Ownership Summary of Robert Edward Sosnowski

Ticker Comapny Transaction Date Type of Owner
CYCC Cyclacel Pharmaceuticals Inc 2011-12-06 VP & Marketing & Sales

Robert Edward Sosnowski Latest Holdings Summary

Robert Edward Sosnowski currently owns a total of 1 stock. Robert Edward Sosnowski owns 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of May 4, 2010, with a value of $0.

Latest Holdings of Robert Edward Sosnowski

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYCC Cyclacel Pharmaceuticals Inc 2010-05-04 0 0.38 0

Holding Weightings of Robert Edward Sosnowski


Robert Edward Sosnowski Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Edward Sosnowski has made a total of 0 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years. The most-recent trade in Cyclacel Pharmaceuticals Inc is the sale of 0 shares on May 4, 2010, which brought Robert Edward Sosnowski around $25,000.

Insider Trading History of Robert Edward Sosnowski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Edward Sosnowski Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Edward Sosnowski Ownership Network

Ownership Network List of Robert Edward Sosnowski

No Data

Ownership Network Relation of Robert Edward Sosnowski

Insider Network Chart

Robert Edward Sosnowski Owned Company Details

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Robert Edward Sosnowski is the VP & Marketing & Sales of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & E.V.P. & Finance & C.O.O. Paul Mcbarron , director & President & C.E.O. Spiro Rombotis , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Robert Edward Sosnowski made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Edward Sosnowski Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Edward Sosnowski. You might contact Robert Edward Sosnowski via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights Nj 07922.